Toxicity of bread wheat lines lacking prolamins encoded by the Gli-B1/Gli-B5/Glu-B3 and Gli-D1/Glu-D3 loci in coeliac disease as determined by their agglutinating activity
By De Vincenzi, M. - Dessi, M.R. - Luchetti, R. - Pogna, N. - Redaelli, R. - Galterio, G.
| Record number: | 2928404 |
|---|---|
| Category: | proteins - wheat flour - lines - toxicity - testing - animal use alternatives |
Peptic-tryptic (PT) digests of alcohol-soluble proteins from the flour of three mutant lines of bread wheat, lacking gamma-gliadins, omega-gliadins and low molecular-weight glutenin subunits encoded by the Cli-B1/Gli-B5/Glu-B3 loci (line S. Pastore 4A), the Gli-D1/Glu-D3 loci (line Alpe 1 I-) or both groups of loci (line DM 22166), were compared with those of the normal cultivars S. Pastore and Alpe 1 I for their agglutinating activities on human myelogenous leukemia K562(S) cells, agglutination being strongly associated with toxicity for the coeliac intestine. All of the genotypes tested contained A-type alpha-gliadins, which constituted about 19% of the gliadins in the S. Pastore and Alpe 1 I cultivars, 24.5%, in the S. Pastore 4A and Alpe 1 I- null lines, and 34.8% in the double mutant line, DM 22166, as determined by densitometric scanning of their acid polyacrylamide gel electrophoresis patterns. The minimal concentrations of PT digest required to agglutinate 100% of K562(S) cells were 73 mg/l and 96 mg/l in the S. Pastore and Alpe 1 I cultivars, respectively, compared with 146 mg/1, 138 mg/l and 200 mg/l in the "null" lines, S. Pastore 4A Alpe 1 I- and DM 22166, respectively. The results implicated that proteins other than alpha-gliadins are involved in the gluten-sensitive enteropathy.
Issued: Jan/Feb 1996
Journal Title: Alternatives to laboratory animals
ISSN: 0261-1929
Volume issue: 24 v. 1 no.
Pages: 39 - 48
AGRICOLA identifier: IND20597409
Takk for din tilbakemelding! Vær oppmerksom på at vi ikke kan kontakte deg hvis ikke du oppgir din epostadresse.
Hva lette du etter?
Gi oss gjerne en tilbakemelding slik at vi kan forbedre informasjonen på siden. På forhånd takk for hjelpen! Vennligst skriv inn din epostadresse hvis du vil ha et svar.
Kontakt oss gjerne på e-post hvis du har spørsmål.